RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells
We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Junqiang Guo & Zhi Lan (2020) PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells. Artif...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Series: | Artificial Cells, Nanomedicine, and Biotechnology |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1699806 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849389767297335296 |
|---|---|
| author | Junqiang Guo Zhi Lan |
| author_facet | Junqiang Guo Zhi Lan |
| author_sort | Junqiang Guo |
| collection | DOAJ |
| description | We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Junqiang Guo & Zhi Lan (2020) PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells. Artificial Cells, Nanomedicine, and Biotechnology, 48(1), 37–45, DOI: 10.1080/21691401.2019.1699806Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to verify their original data or answer our questions about research ethics and the informed consent process. We are therefore retracting this article and the corresponding author listed in this publication has been informed.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. |
| format | Article |
| id | doaj-art-a7bae6f2d5404cb0ab1b3d316fc3134b |
| institution | Kabale University |
| issn | 2169-1401 2169-141X |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Artificial Cells, Nanomedicine, and Biotechnology |
| spelling | doaj-art-a7bae6f2d5404cb0ab1b3d316fc3134b2025-08-20T03:41:52ZengTaylor & Francis GroupArtificial Cells, Nanomedicine, and Biotechnology2169-14012169-141X2020-01-01481374510.1080/21691401.2019.1699806RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cellsJunqiang Guo0Zhi Lan1Department of Trauma Emergency, Huaihe Hospital, Henan University, Kaifeng, ChinaDepartment of Colorectal and Anal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaWe, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Junqiang Guo & Zhi Lan (2020) PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells. Artificial Cells, Nanomedicine, and Biotechnology, 48(1), 37–45, DOI: 10.1080/21691401.2019.1699806Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to verify their original data or answer our questions about research ethics and the informed consent process. We are therefore retracting this article and the corresponding author listed in this publication has been informed.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.https://www.tandfonline.com/doi/10.1080/21691401.2019.1699806 |
| spellingShingle | Junqiang Guo Zhi Lan RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells Artificial Cells, Nanomedicine, and Biotechnology |
| title | RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells |
| title_full | RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells |
| title_fullStr | RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells |
| title_full_unstemmed | RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells |
| title_short | RETRACTED ARTICLE: PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells |
| title_sort | retracted article phd2 acts as an oncogene through activation of ras raf mek erk and jak1 stat3 pathways in human hepatocellular carcinoma cells |
| url | https://www.tandfonline.com/doi/10.1080/21691401.2019.1699806 |
| work_keys_str_mv | AT junqiangguo retractedarticlephd2actsasanoncogenethroughactivationofrasrafmekerkandjak1stat3pathwaysinhumanhepatocellularcarcinomacells AT zhilan retractedarticlephd2actsasanoncogenethroughactivationofrasrafmekerkandjak1stat3pathwaysinhumanhepatocellularcarcinomacells |